Thomas D R, Atkinson P J, Ho M, Bromidge S M, Lovell P J, Villani A J, Hagan J J, Middlemiss D N, Price G W
Department of Neuroscience Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW.
Br J Pharmacol. 2000 May;130(2):409-17. doi: 10.1038/sj.bjp.0703318.
Binding of the 5-HT(7) receptor antagonist radioligand [(3)H]-SB-269970 to human 5-HT(7(a)) receptors expressed in HEK293 cell membranes (h5-HT(7(a))/293) and to guinea-pig cerebral cortex membranes, was characterized and compared with [(3)H]-5-CT binding. [(3)H]-SB-269970 (1 nM) showed full association with h5-HT(7(a))/293 membranes after 40 min. Specific binding at equilibrium represented >90% of total binding and was fully reversible by methiothepin (10 microM), full dissociation occurring by 100 min. The association (k(+1)) and dissociation (k(-1)) rate constants were 0.05 nM(-1)min(-1) and 0.05 min(-1) respectively, giving a K(D) (k(-1)/k(+1)) of 1.0 nM. [(3)H]-SB-269970 bound saturably and apparently monophasically to both h5-HT(7(a))/293 and guinea-pig cortex membranes, with K(D) values of 1.25+/-0.05 and 1.7+/-0.3 nM respectively. The B(max) for [(3)H]-SB-269970 to both h5-HT(7(a))/293 and guinea-pig cortex membranes (5780+/-380 and 125+/-8.2 fmoles mg protein(-1) respectively) was similar to that for [(3)H]-5-CT (6190+/-940 and 143+/-19 fmoles mg protein(-1) respectively). These data suggest that, in each tissue, both radioligands labelled the same population of receptors, which appear to be present in an agonist high affinity state. The profile of compound inhibition of [(3)H]-SB-269970 binding to h5-HT(7(a))/293 and guineapig cortex membranes correlated well (corr. coeff. 0.98) with those for [(3)H]-5-CT binding and were consistent with the profiles reported previously for the human 5-HT(7(a)) and guinea-pig cortex 5-HT(7) receptors using [(3)H]-5-CT. Hill slopes for inhibition of [(3)H]-SB-269970 and [(3)H]-5-CT binding were close to 1, consistent with binding to a single receptor population in both tissues. [(3)H]-SB-269970 represents the first selective 5-HT(7) antagonist radioligand, which should aid further characterization of 5-HT(7) receptors in recombinant and native tissues and help establish their role in brain function.
5-羟色胺(5-HT)7受体拮抗剂放射性配体[³H]-SB-269970与人胚肾293细胞膜(h5-HT(7(a))/293)中表达的人5-HT(7(a))受体以及豚鼠大脑皮层膜的结合特性进行了表征,并与[³H]-5-CT结合进行了比较。[³H]-SB-269970(1 nM)在40分钟后与h5-HT(7(a))/293膜完全结合。平衡时的特异性结合占总结合的>90%,并可被甲硫噻平(10 μM)完全逆转,100分钟时完全解离。结合(k(+1))和解离(k(-1))速率常数分别为0.05 nM⁻¹min⁻¹和0.05 min⁻¹,得出解离常数K(D)(k(-1)/k(+1))为1.0 nM。[³H]-SB-269970与h5-HT(7(a))/293和豚鼠皮层膜均呈饱和且明显单相结合,K(D)值分别为1.25±0.05和1.7±0.3 nM。[³H]-SB-269970与h5-HT(7(a))/293和豚鼠皮层膜的最大结合量(B(max))(分别为5780±380和125±8.2 fmol/mg蛋白)与[³H]-5-CT的相似(分别为6190±940和143±19 fmol/mg蛋白)。这些数据表明,在每个组织中,两种放射性配体标记的是同一受体群体,这些受体似乎以激动剂高亲和力状态存在。[³H]-SB-269970与h5-HT(7(a))/293和豚鼠皮层膜结合的化合物抑制曲线与[³H]-5-CT结合的曲线相关性良好(相关系数0.98),并且与先前使用[³H]-5-CT报道的人5-HT(7(a))和豚鼠皮层5-HT(7)受体的曲线一致。[³H]-SB-269970抑制[³H]-5-CT结合的希尔斜率接近1,这与在两个组织中与单一受体群体结合一致。[³H]-SB-269970是首个选择性5-HT(7)拮抗剂放射性配体,这将有助于进一步表征重组组织和天然组织中的5-HT(7)受体,并有助于确定它们在脑功能中的作用。